These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8394365)
1. Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor. Teicher BA; Holden SA; Khandakar V; Herman TS J Cancer Res Clin Oncol; 1993; 119(11):645-51. PubMed ID: 8394365 [TBL] [Abstract][Full Text] [Related]
2. Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo. Boscia RE; Korbut T; Holden SA; Ara G; Teicher BA Int J Cancer; 1993 Jan; 53(1):118-23. PubMed ID: 8416195 [TBL] [Abstract][Full Text] [Related]
3. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo. Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897 [TBL] [Abstract][Full Text] [Related]
4. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434 [TBL] [Abstract][Full Text] [Related]
5. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Herman TS; Teicher BA; Coleman CN Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171 [TBL] [Abstract][Full Text] [Related]
6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
7. Interaction of ionizing radiation with topotecan in two human tumor cell lines. Marchesini R; Colombo A; Caserini C; Perego P; Supino R; Capranico G; Tronconi M; Zunino F Int J Cancer; 1996 May; 66(3):342-6. PubMed ID: 8621255 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. Kim JH; Kim SH; Kolozsvary A; Khil MS Int J Radiat Oncol Biol Phys; 1992; 22(3):515-8. PubMed ID: 1310495 [TBL] [Abstract][Full Text] [Related]
9. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma. Holden SA; Teicher BA; Herman TS Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503 [TBL] [Abstract][Full Text] [Related]
10. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Mattern MR; Hofmann GA; McCabe FL; Johnson RK Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371 [TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy with bleomycin, hyperthermia, and radiation. Teicher BA; Herman TS; Holden SA Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220 [TBL] [Abstract][Full Text] [Related]
12. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Herman TS; Teicher BA Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430 [TBL] [Abstract][Full Text] [Related]
13. Interaction of PtCl4(Fast Black)2 with hyperthermia. Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969 [TBL] [Abstract][Full Text] [Related]
14. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359 [TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631 [TBL] [Abstract][Full Text] [Related]
16. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo. Kusumoto T; Holden SA; Ara G; Teicher BA Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913 [TBL] [Abstract][Full Text] [Related]
18. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia. Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Alvarez Sotomayor E Cancer Chemother Pharmacol; 1990; 26(2):127-34. PubMed ID: 2347038 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. Kirichenko AV; Rich TA; Newman RA; Travis EL Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Kurtzberg LS; Battle T; Rouleau C; Bagley RG; Agata N; Yao M; Schmid S; Roth S; Crawford J; Krumbholz R; Ewesuedo R; Yu XJ; Wang F; Lavoie EJ; Teicher BA Mol Cancer Ther; 2008 Oct; 7(10):3212-22. PubMed ID: 18852125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]